Sei Investments Co. raised its position in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 72.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 274,011 shares of the company’s stock after purchasing an additional 115,403 shares during the quarter. Sei Investments Co.’s holdings in Doximity were worth $14,629,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also made changes to their positions in DOCS. Global Retirement Partners LLC raised its stake in Doximity by 468.1% during the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock valued at $29,000 after acquiring an additional 440 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of Doximity by 69.1% during the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares during the period. Larson Financial Group LLC raised its stake in shares of Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after purchasing an additional 250 shares in the last quarter. Morse Asset Management Inc acquired a new stake in Doximity in the third quarter worth about $46,000. Finally, IFP Advisors Inc grew its position in Doximity by 344.1% in the 4th quarter. IFP Advisors Inc now owns 1,328 shares of the company’s stock valued at $71,000 after buying an additional 1,029 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on DOCS. Needham & Company LLC upped their price target on shares of Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Canaccord Genuity Group increased their price target on Doximity from $60.00 to $71.00 and gave the company a “hold” rating in a research note on Friday, February 7th. The Goldman Sachs Group lifted their price target on Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Leerink Partners raised Doximity from a “market perform” rating to an “outperform” rating and raised their target price for the company from $60.00 to $90.00 in a research note on Friday, February 7th. Finally, Bank of America boosted their price target on shares of Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $64.22.
Insider Buying and Selling at Doximity
In related news, Director Timothy S. Cabral sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the transaction, the director now directly owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 37.40% of the company’s stock.
Doximity Trading Down 3.6 %
Shares of DOCS stock opened at $58.40 on Friday. The stock’s fifty day simple moving average is $65.48 and its 200-day simple moving average is $54.30. The company has a market capitalization of $10.90 billion, a price-to-earnings ratio of 58.40, a P/E/G ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $85.21.
About Doximity
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
See Also
- Five stocks we like better than Doximity
- What is the Hang Seng index?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- What is Put Option Volume?
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- 3 Dividend Kings To Consider
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.